当前位置: X-MOL 学术Crit. Care › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Relationship between leukopenia and mortality among patients with hematological malignancies
Critical Care ( IF 8.8 ) Pub Date : 2024-12-05 , DOI: 10.1186/s13054-024-05196-4
Caibao Hu, Qian Li, Xinyuan Ding

To the editor,

We read with great interest the recent study [1] published in Critical Care examining sepsis mortality among patients with hematological malignancies admitted to intensive care units between 2000 and 2022. The study’s findings highlighted a notable decline in in-hospital mortality rates for patients with hematological malignancies (from 55.6% in 2000 to 23.1% in 2021) and those without hematological malignancies (from 33.1 to 14.4%). Additionally, the authors reported that, after adjusting for covariates, leukopenia (white cell count < 1.0 × 10⁹ cells/L) was associated with increased mortality in patients without hematological malignancies (p < 0.001) but not in patients with hematological malignancies (p = 0.60).

This is an important clinical topic; however, there may be a potential methodological concern regarding how the relationship between leukopenia and mortality was analyzed. Specifically, the study appears to have created two separate variables in the multivariate logistic regression analysis: one representing leukopenia in patients with hematological malignancies and the other in patients without hematological malignancies—to explore the interaction between leukopenia and hematological malignancy status. While this approach may provide group-specific insights, it can introduce bias and does not adhere fully to the principles of interaction effect analysis.

Interaction effects occur when the impact of one independent variable on a dependent variable is modified by another independent variable. In this study, the association between leukopenia and mortality likely depends on the presence of hematological malignancies. A standard approach to testing this hypothesis is to include an interaction term (e.g., leukopenia × hematological malignancy status) in a unified regression model. This approach avoids splitting the sample or creating separate variables and offers a direct assessment of the interaction effect.

Furthermore, leukopenia was separated into two variables in the current study, and the association between leukopenia and mortality was significant in the crude analysis (OR 2.37, p < 0.001) but became non-significant in the multivariate logistic regression analysis (OR 0.98, p = 0.60). This discrepancy is likely due to multicollinearity. Multicollinearity arises when independent variables are highly correlated, which can distort parameter estimates in regression models. In this context, leukopenia and hematological malignancy are likely strongly correlated, as a substantial proportion of patients with hematological malignancies also exhibit leukopenia. Conversely, leukopenia is far less common among patients without hematological malignancies. This underlying correlation may explain why leukopenia remains significant in one group while becoming non-significant when combined with hematological malignancy in the adjusted logistic model.

Addressing these methodological considerations would enhance the study’s ability to clarify the complex relationship between leukopenia, hematological malignancy status, and mortality. Such clarity would provide more robust evidence to inform clinical decision-making in critical care settings. We commend Dr. MacPhail and colleagues for their valuable contributions to this field.

Not applicable.

  1. MacPhail A, Dendle C, Slavin M, Weinkove R, Bailey M, Pilcher D, McQuilten Z. Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000–2022: a binational cohort study. Crit Care. 2024;28(1):148.

    Article PubMed PubMed Central Google Scholar

Download references

Not applicable.

None.

Authors and Affiliations

  1. Department of Intensive Care, Zhejiang Hospital, No. 1229, Gudun Road, Hangzhou, 310013, Zhejiang, People’s Republic of China

    Caibao Hu

  2. The Second Clinical Medical College of Zhejiang, Chinese Medical University, Hangzhou, 310053, Zhejiang, People’s Republic of China

    Qian Li & Xinyuan Ding

Authors
  1. Caibao HuView author publications

    You can also search for this author in PubMed Google Scholar

  2. Qian LiView author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinyuan DingView author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Caibao Hu and Qian Li wrote the letter and Xinyuan Ding Raised the question. All authors have reviewed and approved the letter.

Corresponding author

Correspondence to Caibao Hu.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, C., Li, Q. & Ding, X. Relationship between leukopenia and mortality among patients with hematological malignancies. Crit Care 28, 402 (2024). https://doi.org/10.1186/s13054-024-05196-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13054-024-05196-4

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

更新日期:2024-12-05
down
wechat
bug